PROSPECTUS D'ADMISSION - Valerio Therapeutics
Prospectus mis à la disposition du public dans le cadre (i) de l'émission et de l'admission aux négociations sur le compartiment C d'Euronext Paris de ...
INTERIM FINANCIAL REPORT THIRD QUARTER AND ... - LED iBondFor Q1-Q3, the company received grants amounting to TDKK 3,073 in total, an increase of TDKK 1,409 or 84.7% over the same period of 2020. Expenses. Total ... Annual Report 2022 - NTI GroupIn 2022, capital expenditure of TDKK 12.987 in proprietary software was capitalised. Expenditure for customer-financed development and certain ... Management's Discussion and AnalysisAt T&D Financial Life, income from insurance premiums was. ¥80.9 billion, a decrease of ¥84.5 billion (down 51.1%) from the previ- ous fiscal year, mainly due ...
Autres Cours:
